Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction

Zhou,Jiansuo; Zhang,Jie

doi:10.3892/mmr.2014.2245

Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction

Authors:
- Jiansuo Zhou
- Jie Zhang
View Affiliations

Affiliations: Department of Laboratory Medicine, Peking University Third Hospital, Haidian, Beijing 100191, P.R. China
Published online on: May 16, 2014 https://doi.org/10.3892/mmr.2014.2245
Pages: 971-976

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the role of microRNA-21 (miR-21) and microRNA-24 (miR-24) in the pathological processes that follow cerebral ischemic injury and examined the potential use of miR-21 and -24 in stroke diagnostics as sensitive plasma biomarkers. An oxygen-glucose deprivation (OGD) model was constructed using mouse N2A neuroblastoma cells (N2A). Western blot analysis and quantitative polymerase chain reaction (qPCR) were employed to detect protein and miRNA expression levels. miR-21 and miR-24 were analyzed in the plasma from 68 patients with acute cerebral infarction (ACI) and 21 healthy individuals. In the present study, it was identified that plasma miR-21 and miR-24 were lower in ACI patients than in the controls (P<0.05). A positive correlation was demonstrated between plasma miR-21 and miR-24, and a negative correlation was revealed between miR-21, miR-24 and the National Institutes of Health Scales Score (NIHSS) within the first day following stroke. In addition, the expression of miR-21 and miR-24 was upregulated by 3.3- and 4.9-fold, respectively, when the reoxygenation time persisted up to 24 h following 3 h of OGD. The expression of Bcl-2 was upregulated following gain of miR-21 function, while X-linked inhibitor of apoptosis protein (XIAP) was downregulated after gain of miR-24 function in N2A cells. The data suggested that miR-21 may have an antiapoptotic effect in N2A neuroblastoma cells following OGD and reoxygenation, while miR-24 may have a pro-apoptotic effect. Therefore, these microRNAs may be potential therapeutic targets for the treatment of post-ischemic injury and may act as diagnostic markers during the early stage of ACI.

View Figures

View References

1	Rink C and Khanna S: MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics. 43:521–528. 2011. View Article : Google Scholar : PubMed/NCBI
2	Laterza OF, Lim L, Garrett-Engele PW, et al: Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem. 55:1977–1983. 2009. View Article : Google Scholar : PubMed/NCBI
3	Weng H, Shen C, Hirokawa G, et al: Plasma miR-124 as a biomarker for cerebral infarction. Biomed Res. 32:135–141. 2011. View Article : Google Scholar : PubMed/NCBI
4	Zeng L, Liu J, Wang Y, et al: MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed). 3:1265–1272. 2011.PubMed/NCBI
5	Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of MicroRNAs in young stroke patients. PLoS One. 4:e76892009. View Article : Google Scholar : PubMed/NCBI
6	Jeyaseelan K, Lim KY and Armugam A: MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 39:959–966. 2008. View Article : Google Scholar : PubMed/NCBI
7	Buller B, Liu X, Wang X, et al: MicroRNA-21 protects neurons from ischemic death. FEBS J. 277:4299–4307. 2010. View Article : Google Scholar : PubMed/NCBI
8	Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF and Srivastava D: miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 208:549–560. 2011. View Article : Google Scholar : PubMed/NCBI
9	Siegel C, Li J, Liu F, Benashski SE and McCullough LD: miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA. 108:11662–11667. 2011. View Article : Google Scholar : PubMed/NCBI
10	Yin KJ, Deng Z, Huang H, et al: miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 38:17–26. 2010. View Article : Google Scholar : PubMed/NCBI
11	Shi L, Chen J, Yang J, Pan T, Zhang S and Wang Z: MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264. 2010. View Article : Google Scholar : PubMed/NCBI
12	Dong J, Zhao YP, Zhou L, Zhang TP and Chen G: Bcl-2 upregulation induced by miR-21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa-2 pancreatic cancer cells. Arch Med Res. 42:8–14. 2011. View Article : Google Scholar
13	McDonald JS, Milosevic D, Reddi HV, Greb SK and Algeciras-Schimnich A: Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 57:833–840. 2011. View Article : Google Scholar : PubMed/NCBI
14	Devaux Y, Vausort M, Goretti E, et al: Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem. 58:559–567. 2012. View Article : Google Scholar : PubMed/NCBI
15	Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
16	Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yao R, Ma Y, Du Y, et al: The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell Mol Immunol. 8:486–495. 2011. View Article : Google Scholar : PubMed/NCBI
18	Kroh EM, Parkin RK, Mitchell PS and Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
19	Fichtlscherer S, Zeiher AM and Dimmeler S: Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol. 31:2383–2390. 2011. View Article : Google Scholar : PubMed/NCBI
20	Lorenzen JM and Thum T: Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol. 7:1528–1533. 2012. View Article : Google Scholar : PubMed/NCBI
21	Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
22	Doyle KP, Simon RP and Stenzel-Poore MP: Mechanisms of ischemic brain damage. Neuropharmacology. 55:310–318. 2008. View Article : Google Scholar : PubMed/NCBI
23	Xie Y, Tobin LA, Camps J, et al: MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene. 32:2442–2451. 2012. View Article : Google Scholar : PubMed/NCBI
24	Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
25	Papagiannakopoulos T, Shapiro A and Kosik KS: MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI